Ligand structure-dependent activation of estrogen receptor α/Sp by estrogens and xenoestrogens

Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, United States.
The Journal of Steroid Biochemistry and Molecular Biology (Impact Factor: 3.63). 06/2008; 110(1-2):104-15. DOI: 10.1016/j.jsbmb.2008.02.008
Source: PubMed


This study investigated the effects of E2, diethylstilbestrol (DES), antiestrogens, the phytoestrogen resveratrol, and the xenoestrogens octylphenol (OP), nonylphenol (NP), endosulfan, kepone, 2,3,4,5-tetrachlorobiphenyl-4-ol (HO-PCB-Cl(4)), bisphenol-A (BPA), and 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) on induction of luciferase activity in breast cancer cells transfected with a construct (pSp1(3)) containing three tandem GC-rich Sp binding sites linked to luciferase and wild-type or variant ERalpha. The results showed that induction of luciferase activity was highly structure-dependent in both MCF-7 and MDA-MB-231 cells. Moreover, RNA interference assays using small inhibitory RNAs for Sp1, Sp3 and Sp4 also demonstrated structure-dependent differences in activation of ERalpha/Sp1, ERalpha/Sp3 and ERalpha/Sp4. These results demonstrate for the first time that various structural classes of ER ligands differentially activate wild-type and variant ERalpha/Sp-dependent transactivation, selectively use different Sp proteins, and exhibit selective ER modulator (SERM)-like activity.

Download full-text


Available from: Rola Barhoumi
  • Source
    • "Similarly, during a woman's lifetime, potency differences dictate which estrogenic hormone is dominant – 17b- estradiol > estrone > estriol – yet even these differences span less than two orders of magnitude (Chen et al., 2004; Kuiper et al., 1997). In contrast, putative environmental estrogens exhibit potencies three or more orders of magnitude below that of 17b- estradiol (Borgert et al., 2003; Wu et al., 2008), indicating a low potential for estrogenic activity. Since circulating endogenous estrogen concentrations are several hundred times greater in women compared to rodent test species, an inference of human risk from low-potency chemicals based on endocrine disruptive effects observed in those species would be speculative (Witorsch, 2002). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Whether thresholds exist for endocrine active substances and for endocrine disrupting effects of exogenous chemicals has been posed as a question for regulatory policy by the European Union. This question arises from a concern that the endocrine system is too complex to allow estimations of safe levels of exposure to any chemical with potential endocrine activity, and a belief that any such chemical can augment, retard, or disrupt the normal background activity of endogenous hormones. However, vital signaling functions of the endocrine system require it to continuously discriminate the biological information conveyed by potent endogenous hormones from a more concentrated background of structurally similar, endogenous molecules with low hormonal potential. This obligatory ability to discriminate important hormonal signals from background noise can be used to define thresholds for induction of hormonal effects, without which normal physiological functions would be impossible. From such thresholds, safe levels of exposure can be estimated. This brief review highlights how the fundamental principles governing hormonal effects - affinity, efficacy, potency, and mass action - dictate the existence of thresholds and why these principles also define the potential that exogenous chemicals might have to interfere with normal endocrine functioning.
    Full-text · Article · Jul 2013 · Regulatory Toxicology and Pharmacology
  • Source
    • "During the course of these studies, we observed unexpectedly that RSV treatment in control female mouse strongly increases the dopamine transporter (DAT) levels in the striatum. RSV is a phytoestrogen with striking similarity to the synthetic estrogen diethylstilbestrol, and available data suggests that RSV may be an estrogen receptors (ERs) agonist (Gehm et al., 1997) that bind to both ERa-and ERb (Bowers et al., 2000; Mueller et al., 2004; Robb and Stuart, 2011; Wu et al., 2008). In view of this we were interested to study whether the RSV may have gender-specific effects in "
    [Show abstract] [Hide abstract]
    ABSTRACT: Treatment with resveratrol (RSV) has been shown to protect vulnerable neurons after various brain injuries and in neurodegenerative diseases. The mechanisms for the effects of RSV in brain are not fully understood, but RSV may affect the expression of various gene products. RSV is structurally related to the synthetic estrogen, diethylstilbestrol so the effects of RSV may be gender-specific. Here we studied the role of RSV in the regulation of dopamine transporter (DAT) in the striatum using male and female mice. The basic levels of DAT in the striatum showed no sex difference, but the levels increased significantly by RSV (20 mg/kg i.p.) in female but not in male mice. Pretreatment of mice with the selective estrogen receptor (ER), ERα- and ERβ antagonist ICI 182,780, led to a complete block of RSV effect on DAT protein levels, suggesting that ERs are involved in the up-regulation of DAT by RSV. Similar data was also obtained in culture using human MESC2.10 and mouse SN4741 dopaminergic cells after treatment with RSV. Data further showed that RSV specifically induced gene transcription of DAT in the dopaminergic cells. These results show that estrogen receptors are involved in the up-regulation of DAT by RSV in the dopaminergic neurons, demonstrating a sex-dependent effect of RSV in the brain that may be of clinical importance. This article is part of a Special Issue entitled 'Post-Traumatic Stress Disorder'.
    Full-text · Article · Feb 2012 · Neuropharmacology
  • Source
    • "Because this second mecha nism results in ERα being indirectly " tethered " to DNA motifs, it is sometimes referred to as the tethered mechanism. Studies have indicated that this tethered pathway is sensitive to xenoestrogenic endocrine-disrupting compounds (Fujimoto et al. 2004; Safe and Kim 2008; Wu et al. 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Interest and concern regarding potentially estrogenic substances have resulted in development of model systems to evaluate mechanisms of such chemicals. Microarray studies have indicated that estradiol (E2)-stimulated uterine responses can be divided into early and late phases. Comparison of E2 uterine transcript profiles and those of other estrogenic chemicals of interest in vivo indicates mechanisms and activities of test compounds. We compared transcript responses and mechanisms of response using mouse reproductive tracts after treatment with E2, estriol (E3), bisphenol A (BPA), and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE). Uterine RNA from ovariectomized wild-type mice, estrogen receptor α (ERα) knockout (αERKO) mice, and mice expressing a DNA-binding-deficient ERα (KIKO) treated with E2, E3, BPA, or HPTE for 2 or 24 hr was analyzed by microarray. Resulting regulated transcripts were compared by hierarchical clustering and correlation analysis, and response patterns were verified by reverse-transcription real-time polymerase chain reaction (RT-PCR). Both xenoestrogens, BPA and HPTE, showed profiles highly correlated to that of E2 in the early response phase (2 hr), but the correlation diminished in the later response phase (24 hr), similar to the known weak estrogen E3. Both xenoestrogens also mimicked E2 in samples from KIKO mice, indicating that they are able to utilize the indirect tethering mode of ERα signaling. No response was detected in ERα-null uteri, indicating that ERα mediates the responses. Our study forms a basis on which patterns of response and molecular mechanisms of potentially estrogenic chemicals can be assessed.
    Full-text · Article · Jan 2011 · Environmental Health Perspectives
Show more